Filing Flows

Filing Flows › Neogenomics (NEO) › Next earnings date

Neogenomics (NEO) earnings

Neogenomics (NEO) last reported on Oct 28, 2026: revenue $209M for the third quarter 2026. The next date is not set yet. It beat the EPS estimate in 100% of the quarters on record.

Beat rate100%

The last report

Neogenomics reported revenue of $209M for the third quarter 2026 (+11% Y/Y), net loss $7.5M: Client direct billing $136M, Commercial insurance $44.7M, Medicare and other government $29.0M. How it makes money → · Every quarter →

Neogenomics: EPS against the estimate, last 5 reportsNeogenomics: EPS against the estimate, last 5 reportsEstimateReported$0.02$0.03Oct 25$0.04$0.06Feb 26$0.00$0.01Apr 26$0.03$0.05Jul 26$0.06$0.07Oct 26
Latest (Oct 26): Estimate $0.06, Reported $0.07.

Neogenomics' latest quarter

Neogenomics, Q3 2026: revenue $209M (+11% year over year), operating margin -3.8%, net loss $7.5M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.

Questions

When does NEO report earnings?

The next date is not set yet.

Does Neogenomics usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.